Flow cell (R9.4) bulk order of 12, ligation sequencing kits, and control expansion.
Ended Purchase Order Awarded Last action
- Contract number
- 75N90020P00427
- Awardee
-
Oxford Nanopore Technologies, Inc. UEI FM6MMNBM2TQ5 Part of Oxford Nanopore Technologies PLC
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,086
Award facts
- Contract value 100% obligated
- $12,086.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
About this award
The NIH Clinical Center awarded a purchase order to Oxford Nanopore Technologies Inc. for $12,086.00 on May 12, 2020, for a bulk order of 12 flow cells (R9.4), ligation sequencing kits, and control expansion. Performance of the order occurred in Cambridge, Massachusetts, with an ultimate completion date of July 13, 2020. The order was priced on a firm fixed-price basis with no small business set-aside.
Quick answers
Who was awarded contract 75N90020P00427?
75N90020P00427 was awarded to Oxford Nanopore Technologies, Inc. by NIH Clinical Center (National Institutes of Health) on May 12, 2020.
How much is contract 75N90020P00427 worth?
The government has obligated $12,086 on 75N90020P00427.
Was contract 75N90020P00427 competed?
The extent of competition for 75N90020P00427 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award